Drugmakers say Biden misguided over patent waiver
The Hindu
U.S. President supports waiving intellectual property rights for COVID vaccines
Drugmakers on Thursday said U.S. President Joe Biden’s could disrupt a fragile supply chain and that rich countries should instead share more generously with the developing world. Mr. Biden on Wednesday threw his support behind waiving intellectual property rights for COVID-19 vaccines, angering research-based pharmaceutical companies. If adopted by the WTO, the proposal would invite new manufacturers that lack essential know-how and oversight from the inventors to crowd out established contractors, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) said.More Related News

Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.












